| Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Corporate Authors: AE-TBC Consortium
- Publication Type: Journal Article; Research Support, Non-U.S. Gov't
- Language: English
- [Tuberculosis (Edinb)] 2022 Mar; Vol. 133, pp. 102169. <i>Date of Electronic Publication: </i>2022 Jan 31.
- MeSH Terms: Mycobacterium tuberculosis* ; Tuberculosis* / microbiology ; Antibodies, Bacterial ; Antigens, Bacterial ; Cytokines ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunoglobulin A ; Sensitivity and Specificity
- Grant Information: MC_U190071468 United Kingdom MRC_ Medical Research Council; MC_UP_A900_1122 United Kingdom MRC_ Medical Research Council; MC_UU_00031/6 United Kingdom MRC_ Medical Research Council; MR/P017568/1 United Kingdom MRC_ Medical Research Council
- Contributed Indexing: Investigator: G Walzl, Stellenbosch University, South Africa.; NN Chegou, Stellenbosch University, South Africa.; M Kriel, Stellenbosch University, South Africa.; G van der Spuy, Stellenbosch University, South Africa.; AG Loxton, Stellenbosch University, South Africa.; K Stanley, Stellenbosch University, South Africa.; ST Malherbe, Stellenbosch University, South Africa.; B Kriel, Stellenbosch University, South Africa.; JS Sutherland, MRC Unit, The Gambia at LSHTM, South Africa.; O Owolabi, MRC Unit, The Gambia at LSHTM, South Africa.; A Sillah, MRC Unit, The Gambia at LSHTM, South Africa.; J Mendy, MRC Unit, The Gambia at LSHTM, South Africa.; A Gindeh, MRC Unit, The Gambia at LSHTM, South Africa.; S Donkor, MRC Unit, The Gambia at LSHTM, South Africa.; T Togun, MRC Unit, The Gambia at LSHTM, South Africa.; M Ota, MRC Unit, The Gambia at LSHTM, South Africa.; AC Crampin, Karonga Prevention Study, Malawi.; F Simukonda, Karonga Prevention Study, Malawi.; A Amberbir, Karonga Prevention Study, Malawi.; F Chilongo, Karonga Prevention Study, Malawi.; R Houben, Karonga Prevention Study, Malawi.; D Kassa, Ethiopian Health and Nutrition Research Institute (now known as the Ethiopian Public Health Institute), Ethiopia.; A Gebrezgeabher, Ethiopian Health and Nutrition Research Institute (now known as the Ethiopian Public Health Institute), Ethiopia.; G Mesfin, Ethiopian Health and Nutrition Research Institute (now known as the Ethiopian Public Health Institute), Ethiopia.; Y Belay, Ethiopian Health and Nutrition Research Institute (now known as the Ethiopian Public Health Institute), Ethiopia.; G Gebremichael, Ethiopian Health and Nutrition Research Institute (now known as the Ethiopian Public Health Institute), Ethiopia.; Y Alemayehu, Ethiopian Health and Nutrition Research Institute (now known as the Ethiopian Public Health Institute), Ethiopia.; M van der Vyver, University of Namibia, Namibia.; FN Amutenya, University of Namibia, Namibia.; JN Nelongo, University of Namibia, Namibia.; L Monye, University of Namibia, Namibia.; JA Sheehama, University of Namibia, Namibia.; S Iipinge, University of Namibia, Namibia.; H Mayanja-Kizza, Makerere University, Uganda.; AR Namuganga, Makerere University, Uganda.; G Muzanye, Makerere University, Uganda.; M Nsereko, Makerere University, Uganda.; P Peters, Makerere University, Uganda.; R Howe, Armauer Hansen Research Institute, Ethiopia.; A Mihret, Armauer Hansen Research Institute, Ethiopia.; Y Bekele, Armauer Hansen Research Institute, Ethiopia.; B Tessema, Armauer Hansen Research Institute, Ethiopia.; L Yamuah, Armauer Hansen Research Institute, Ethiopia.; THM Ottenhoff, Department of Infectious Diseases, Leiden University Medical Centre, the Netherlands.; A Geluk, Department of Infectious Diseases, Leiden University Medical Centre, the Netherlands.; K Franken, Department of Infectious Diseases, Leiden University Medical Centre, the Netherlands.; JJ van der Ploeg-van Schip, Department of Infectious Diseases, Leiden University Medical Centre, the Netherlands.; PLAM Corstjens, Department of Molecular Cell Biology, Leiden University Medical Centre, the Netherlands.; EM Tjon Kon Fat, Department of Molecular Cell Biology, Leiden University Medical Centre, the Netherlands.; CJ de Dood, Department of Molecular Cell Biology, Leiden University Medical Centre, the Netherlands.; I Rosenkrands, Statens Serum Institute, Copenhagen, Denmark.; C Aagaard, Statens Serum Institute, Copenhagen, Denmark.; SHE Kaufmann, Max Planck Institute for Infection Biology, Berlin, Germany.; MM Esterhuyse, Max Planck Institute for Infection Biology, Berlin, Germany.; JM Cliff, London School of Hygiene and Tropical Medicine, London, UK.; HM Dockrell, London School of Hygiene and Tropical Medicine, London, UK. ; Keywords: Antibodies; Antigens; Biomarkers; Cytokines; Diagnosis; Tuberculosis
- Substance Nomenclature: 0 (Antibodies, Bacterial) ; 0 (Antigens, Bacterial) ; 0 (Cytokines) ; 0 (Immunoglobulin A) ; 144058-44-6 (Mycobacterium tuberculosis antigens)
- Entry Date(s): Date Created: 20220205 Date Completed: 20220504 Latest Revision: 20230322
- Update Code: 20240513
|
